I don't know, Rocket - so far, I believe, the work was based on...

I don't know, Rocket - so far, I believe, the work was based on mice? Then again, I'd find it hard to remember - I've been reading too much. ;-)

Here is some more information on Cellmid's antibodies for fracture healing:

New research backs CDY’s MK plan for osteoporosis
https://finfeed.com/small-caps/biotech/new-research-backs-cdys-mk-plan-osteoporosis/

Here is Melanie Haffner-Luntzer's work from 2016:

Inhibition of Midkine Augments Osteoporotic Fracture Healing
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0159278

Earlier work by Liedert:The role of midkine in skeletal remodelling
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925025/

Cellmid's announcement as a PDF can be found here.

Recent patent:
https://patentscope.wipo.int/search...cAn=AU2017050179&queryString=&maxRec=65223986